Skip to content

Opening book details…

About this Medicine article

Secukinumab is Superior to Fumaric Acid Esters in Treating Subjects with Moderate to Severe Plaque Psoriasis who are Naïve to Systemic Treatments: Results from the Randomized Controlled PRIME Trial by Sticherling, M.; Mrowietz, U.; Augustin, M.; Thaçi, D.; Melzer, N.; Hentschke, C.; Kneidl, J.; Sieder, C.; Reich, K. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Sticherling, M.; Mrowietz, U.; Augustin, M.; Thaçi, D.; Melzer, N.; Hentschke, C.; Kneidl, J.; Sieder, C.; Reich, K.
Publisher
John Wiley and Sons; Wiley (Blackwell Publishing); Blackwell Publishing Inc.; Wiley; Springer Science and Business Media LLC (ISSN 0007-0963)
Published
2017
Language
EN
Field
Medicine (Health Sciences)

More by Sticherling, M.; Mrowietz, U.; Augustin, M.; Thaçi, D.; Melzer, N.; Hentschke, C.; Kneidl, J.; Sieder, C.; Reich, K.

Browse all works by Sticherling, M.; Mrowietz, U.; Augustin, M.; Thaçi, D.; Melzer, N.; Hentschke, C.; Kneidl, J.; Sieder, C.; Reich, K.